Table: begin end state 1 11 cytoplasmic 12 33 transmembrane 34 52 non-cytoplasmic 53 76 transmembrane 77 85 cytoplasmic 86 105 transmembrane 106 110 non-cytoplasmic 111 132 transmembrane 133 144 cytoplasmic 145 167 transmembrane 168 186 non-cytoplasmic 187 206 transmembrane 207 264 cytoplasmic 265 288 transmembrane 289 302 non-cytoplasmic 303 324 transmembrane 325 331 cytoplasmic 332 352 transmembrane 353 371 non-cytoplasmic 372 395 transmembrane 396 406 cytoplasmic 407 426 transmembrane 427 435 non-cytoplasmic 436 457 transmembrane 458 469 cytoplasmic
Input: >WP_027721048.1 NCBI__GCF_000425265.1:WP_027721048.1 MISAPTSDKQPACIAFVLLLSTAAALGGFLFGFDTAVINGAVIALGDYFKVGPVLVGMSV SLALLGSAVGALGSGYISDKYGRIKGMMLAAVLFTASGVGAGLPFTVWDFIFWRILGGIG IGLASAITPAYIAEISPASLRGRFGSLQQLAIVVGIFIAMLSNYMLVEVAGGSAGNELWF GFETWRWMFWAEVPPALLYLIASMMIPESPRYLIGRGRETEAHEILGKVIGDSVLEKIEE IKVTLQVEGGAAFADIKGRIGFKHIVWLGLGLSVLQQFVGINVIFYYGSMLWRSVGFTEQ HSLWITVVTGIVNIVTTLIAIVFIDCIGRKPLLLSGSAGMVITLGILAYLFGTAPLDAAG NPKLIGETATTALVAANIYVFCFGFSWGPVVWVLLGEMFNNRMRASALALGAGAQWVANF VVSASFPSLVEWVGLGFTYLGYTFFAAVSFFFVMFLIRETRGRELEDME
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server